vs
Side-by-side financial comparison of Privia Health Group, Inc. (PRVA) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Privia Health Group, Inc. is the larger business by last-quarter revenue ($541.2M vs $340.0M, roughly 1.6× Walker & Dunlop, Inc.). Privia Health Group, Inc. runs the higher net margin — 1.7% vs -12.9%, a 14.6% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -0.4%). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs 14.2%).
Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
PRVA vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $541.2M | $340.0M |
| Net Profit | $9.2M | $-13.9M |
| Gross Margin | — | — |
| Operating Margin | 2.1% | -17.2% |
| Net Margin | 1.7% | -12.9% |
| Revenue YoY | 17.4% | -0.4% |
| Net Profit YoY | 108.0% | -131.0% |
| EPS (diluted) | $0.08 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $541.2M | $340.0M | ||
| Q3 25 | $580.4M | $337.7M | ||
| Q2 25 | $521.2M | $319.2M | ||
| Q1 25 | $480.1M | $237.4M | ||
| Q4 24 | $460.9M | $341.5M | ||
| Q3 24 | $437.9M | $292.3M | ||
| Q2 24 | $422.3M | $270.7M | ||
| Q1 24 | $415.2M | $228.1M |
| Q4 25 | $9.2M | $-13.9M | ||
| Q3 25 | $6.9M | $33.5M | ||
| Q2 25 | $2.7M | $34.0M | ||
| Q1 25 | $4.2M | $2.8M | ||
| Q4 24 | $4.4M | $44.8M | ||
| Q3 24 | $3.5M | $28.8M | ||
| Q2 24 | $3.5M | $22.7M | ||
| Q1 24 | $3.0M | $11.9M |
| Q4 25 | 2.1% | -17.2% | ||
| Q3 25 | 2.5% | 13.6% | ||
| Q2 25 | 0.6% | 14.5% | ||
| Q1 25 | 1.1% | 2.2% | ||
| Q4 24 | 1.1% | 15.3% | ||
| Q3 24 | 1.3% | 12.8% | ||
| Q2 24 | 1.2% | 10.4% | ||
| Q1 24 | 0.2% | 6.0% |
| Q4 25 | 1.7% | -12.9% | ||
| Q3 25 | 1.2% | 9.9% | ||
| Q2 25 | 0.5% | 10.6% | ||
| Q1 25 | 0.9% | 1.2% | ||
| Q4 24 | 1.0% | 13.1% | ||
| Q3 24 | 0.8% | 9.9% | ||
| Q2 24 | 0.8% | 8.4% | ||
| Q1 24 | 0.7% | 5.2% |
| Q4 25 | $0.08 | $-0.41 | ||
| Q3 25 | $0.05 | $0.98 | ||
| Q2 25 | $0.02 | $0.99 | ||
| Q1 25 | $0.03 | $0.08 | ||
| Q4 24 | $0.03 | $1.32 | ||
| Q3 24 | $0.03 | $0.85 | ||
| Q2 24 | $0.03 | $0.67 | ||
| Q1 24 | $0.02 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $479.7M | $299.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $737.2M | $1.7B |
| Total Assets | $1.4B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $479.7M | $299.3M | ||
| Q3 25 | $441.4M | $274.8M | ||
| Q2 25 | $390.1M | $233.7M | ||
| Q1 25 | $469.3M | $181.0M | ||
| Q4 24 | $491.1M | $279.3M | ||
| Q3 24 | $422.0M | $179.8M | ||
| Q2 24 | $387.4M | $208.1M | ||
| Q1 24 | $351.1M | $216.5M |
| Q4 25 | $737.2M | $1.7B | ||
| Q3 25 | $709.1M | $1.8B | ||
| Q2 25 | $682.9M | $1.8B | ||
| Q1 25 | $659.4M | $1.7B | ||
| Q4 24 | $635.2M | $1.7B | ||
| Q3 24 | $614.9M | $1.7B | ||
| Q2 24 | $595.4M | $1.7B | ||
| Q1 24 | $576.8M | $1.7B |
| Q4 25 | $1.4B | $5.1B | ||
| Q3 25 | $1.4B | $5.8B | ||
| Q2 25 | $1.3B | $4.7B | ||
| Q1 25 | $1.2B | $4.5B | ||
| Q4 24 | $1.1B | $4.4B | ||
| Q3 24 | $1.1B | $4.6B | ||
| Q2 24 | $1.1B | $4.2B | ||
| Q1 24 | $1.0B | $3.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $127.5M | $-664.3M |
| Free Cash FlowOCF − Capex | — | $-680.1M |
| FCF MarginFCF / Revenue | — | -200.0% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | 13.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $127.5M | $-664.3M | ||
| Q3 25 | $52.0M | $-948.1M | ||
| Q2 25 | $8.0M | $-238.5M | ||
| Q1 25 | $-24.1M | $-281.1M | ||
| Q4 24 | $74.8M | $129.4M | ||
| Q3 24 | $33.2M | $-202.0M | ||
| Q2 24 | $34.5M | $-237.8M | ||
| Q1 24 | $-33.1M | $38.4M |
| Q4 25 | — | $-680.1M | ||
| Q3 25 | — | $-950.4M | ||
| Q2 25 | — | $-241.0M | ||
| Q1 25 | — | $-284.7M | ||
| Q4 24 | — | $116.4M | ||
| Q3 24 | — | $-204.0M | ||
| Q2 24 | — | $-241.7M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | — | -200.0% | ||
| Q3 25 | — | -281.5% | ||
| Q2 25 | — | -75.5% | ||
| Q1 25 | — | -120.0% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | -69.8% | ||
| Q2 24 | — | -89.3% | ||
| Q1 24 | — | 15.4% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 13.93× | — | ||
| Q3 25 | 7.58× | -28.34× | ||
| Q2 25 | 2.97× | -7.02× | ||
| Q1 25 | -5.70× | -102.07× | ||
| Q4 24 | 17.00× | 2.89× | ||
| Q3 24 | 9.38× | -7.01× | ||
| Q2 24 | 9.94× | -10.49× | ||
| Q1 24 | -11.10× | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
WD
Segment breakdown not available.
